| study used NMR to obtain detailed mechanistic data on RAS cycling defects conferred by oncogenic mutations, or full-length RASopathy-derived regulatory proteins | None |
| study elucidates a novel correlation between the tumor suppressor gene p53 and the oncogene Ras in regulating EMT program, and expands the knowledge about the function of p53 in EMT process | None |
| p53 Attenuates the oncogenic Ras-induced epithelial-mesenchymal transition in human mammary epithelial cells. | None |
| Twenty-one proteins up-regulated in human H-ras oncogene transgenic rat pancreas cancers are up-regulated in human pancreas cancer. | None |
| Data indicate oncogenic HRAS (HRAS(G12V)) as a potent mediator of SLC5A8 silencing in human nontransformed normal mammary epithelial cell lines and in mouse mammary tumors through DNMT1. | None |
| Altered glucose metabolism in Harvey-ras transformed MCF10A cells. | None |
| These results provide evidence for a role of H-ras oncogene in the metabolic reprogramming of MCF10A cells during early mammary carcinogenesis. | None |
| An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue. | None |
| DNA methylation affecting the transforming activity of the human Ha-ras oncogene. | None |
| Interferon-induced phenotypic changes in human tumor cells relative to the effects of interferon on c-ras oncogene expression. | None |
| Morphological transformation, focus formation, and anchorage independence induced in diploid human fibroblasts by expression of a transfected H-ras oncogene. | None |
| Three-dimensional structure of an oncogene protein: catalytic domain of human c-H-ras p21. | None |
| Antisera to the variable region of ras oncogene proteins, and specific detection of H-ras expression in an experimental model of chemical carcinogenesis. | None |
| The effects of hydrocortisone on c-fos, c-myc and c-ras oncogene expression in IMR-90 fibroblasts. | None |
| Cells that overproduce protein kinase C are more susceptible to transformation by an activated H-ras oncogene. | None |
| Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation. | None |
| MicroRNA 17-92 cluster mediates ETS1 and ETS2-dependent RAS-oncogenic transformation | None |
| The cellular response to induction of the p21 c-Ha-ras oncoprotein includes stimulation of jun gene expression. | None |
| The 5 flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. | None |
| BLT2 is markedly up-regulated by oncogenic Ras and promotes epithelial-mesenchymal transition in response to TGF-beta in mammary epithelial cells. | None |